Get the Stockscreener App
11.00
1.26%
-0.14
After Hours:
11.00
Enfusion Inc stock is traded at $11.00, with a volume of 1.54M.
It is down -1.26% in the last 24 hours and down -3.25% over the past month.
Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. The products and services that comprise its solution are designed to eliminate technology and information barriers, empowering investment managers to confidently make and execute better-informed investment decisions in real time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth. It generates maximum revenue from the Americas, followed by Asia Pacific and Europe, the Middle East, and Africa.
See More
Previous Close:
$11.14
Open:
$11.05
24h Volume:
1.54M
Relative Volume:
1.49
Market Cap:
$1.04B
Revenue:
$174.54M
Net Income/Loss:
$6.03M
P/E Ratio:
137.50
EPS:
0.08
Net Cash Flow:
$15.96M
1W Performance:
-1.26%
1M Performance:
-3.25%
6M Performance:
+23.46%
1Y Performance:
+18.03%
1-Day Range:
$10.99
$11.11
1-Week Range:
$10.99
$11.17
52-Week Range:
$7.83
$11.80
Enfusion Inc Stock (ENFN) Company Profile
Name
Enfusion Inc
Sector
Industry
Phone
(312) 253-9800
Address
125 SOUTH CLARK STREET, SUITE 750, CHICAGO
Compare ENFN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENFN
Enfusion Inc
|
11.00 | 1.04B | 174.54M | 6.03M | 15.96M | 0.08 |
|
SAP
Sap Se Adr
|
264.34 | 308.38B | 36.97B | 3.37B | 4.79B | 2.8498 |
|
CRM
Salesforce Inc
|
255.23 | 245.28B | 37.90B | 6.20B | 12.43B | 6.36 |
|
INTU
Intuit Inc
|
598.53 | 167.33B | 17.17B | 3.04B | 5.63B | 10.72 |
|
NOW
Servicenow Inc
|
774.07 | 159.84B | 10.98B | 1.43B | 3.38B | 6.83 |
|
ADBE
Adobe Inc
|
367.25 | 156.52B | 22.04B | 6.75B | 9.19B | 15.18 |
Enfusion Inc Stock (ENFN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-10-24 | Resumed | Morgan Stanley | Overweight |
| Feb-28-24 | Downgrade | Goldman | Neutral → Sell |
| Jan-30-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-07-23 | Initiated | UBS | Neutral |
| Apr-03-23 | Initiated | Piper Sandler | Neutral |
| Mar-15-23 | Initiated | JP Morgan | Neutral |
| Jan-04-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-03-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-03-22 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-15-21 | Initiated | BofA Securities | Buy |
| Nov-15-21 | Initiated | Credit Suisse | Neutral |
| Nov-15-21 | Initiated | Goldman | Neutral |
| Nov-15-21 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-15-21 | Initiated | Piper Sandler | Overweight |
| Nov-15-21 | Initiated | Stifel | Buy |
| Nov-15-21 | Initiated | William Blair | Outperform |
View All
Enfusion Inc Stock (ENFN) Latest News
Clearwater Analytics and Enfusion Announce Election Deadline for Enfusion Shareholders to Elect Form of Merger Consideration - 01net
Critical Merger Deadline: Enfusion Shareholders Must Choose Payment Type by April 16 - Stock Titan
ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc.ENFN - Business Wire
Learn to Evaluate (ENFN) using the Charts - news.stocktradersdaily.com
Shareholder Rights Advocates at Levi & Korsinsky Investigate Enfusion, Inc. (ENFN) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Lost Money on Enfusion, Inc. (ENFN)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire
Bank of New York Mellon Corp Increases Stock Holdings in Enfusion, Inc. (NYSE:ENFN) - Defense World
MS cuts rating on Enfusion stock after Clearwater’s acquisition bid - MSN
(ENFN) Trading Report - Stock Traders Daily
Enfusion, Inc. Reports Strong Growth Amid Acquisition Plans - MSN
Enfusion (ENFN) to Release Earnings on Tuesday - Defense World
Enfusion CEO Oleg Movchan sells $130,472 in stock By Investing.com - Investing.com South Africa
Rhumbline Advisers Has $643,000 Stake in Enfusion, Inc. (NYSE:ENFN) - Defense World
Enfusion’s chief people officer sells shares worth $35,558 - Investing.com India
Enfusion CFO sells $52,836 in stock to cover tax obligations By Investing.com - Investing.com Canada
Enfusion Executives Cash In: Major Stock Sales Unveiled! - TipRanks
Enfusion chief accounting officer sells $6,165 in stock By Investing.com - Investing.com Canada
Enfusion’s general counsel Matthew Campobasso sells $19,280 in stock - Investing.com
Enfusion chief accounting officer sells $6,165 in stock - Investing.com
Enfusion COO Neal Pawar sells $165,620 in stock - Investing.com
Enfusion’s chief people officer sells shares worth $35,558 By Investing.com - Investing.com South Africa
Enfusion Executives Sell Shares to Cover Tax Obligations - TradingView
Enfusion’s Hold Rating: Balancing Strategic Merger Benefits with Market Uncertainties - TipRanks
Enfusion CEO Oleg Movchan sells $130,472 in stock - Investing.com
Enfusion’s CAO Makes a Noteworthy Stock Sale! - TipRanks
Enfusion’s general counsel sells $12,410 in stock to cover taxes By Investing.com - Investing.com South Africa
Enfusion COO Neal Pawar sells $31,790 in stock - Investing.com India
Enfusion Executives Unload Major Stock Holdings! - TipRanks
Enfusion COO Neal Pawar sells $31,790 in stock By Investing.com - Investing.com Canada
Enfusion chief accounting officer sells $2,514 in stock - Investing.com Australia
Enfusion chief accounting officer sells $2,514 in stock By Investing.com - Investing.com South Africa
Enfusion CEO Oleg Movchan sells $32,031 in stock By Investing.com - Investing.com Canada
Enfusion CFO Bradley Herring sells $17,600 in stock By Investing.com - Investing.com South Africa
Enfusion’s chief people officer sells shares worth $23,696 - Investing.com India
Enfusion CEO Oleg Movchan sells $32,031 in stock - Investing.com
Enfusion’s chief people officer sells shares worth $23,696 By Investing.com - Investing.com South Africa
Stifel maintains Enfusion stock Hold rating, $11.25 target By Investing.com - Investing.com Canada
Stifel maintains Enfusion stock Hold rating, $11.25 target - Investing.com India
Enfusion, Inc. (ENFN) Lags Q4 Earnings and Revenue Estimates - MSN
Enfusion earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada
Enfusion Q4 Adjusted Earnings Fall, Revenue Rises -March 03, 2025 at 05:38 pm EST - Marketscreener.com
Enfusion Announces Fourth Quarter and Full Year 2024 Results - TradingView
Earnings Flash (ENFN) ENFUSION INC. Reports Q4 Revenue $52.9M, vs. FactSet Est of $54.3M - Marketscreener.com
Enfusion Inc Stock (ENFN) Financials Data
Revenue
Net Income
Cash Flow
EPS
9.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):